Hemab is a clinical-stage biotech company developing prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.
Market
Therapeutics for bleeding and thrombotic disorders
Location
Cambridge,
MA,
USA
Coinvestors
Access Biotechnology, Avoro Ventures, Deep Track Capital, HealthCap, Invus, Maj Invest Equity, Novo Holdings, RA Capital Management, Rock Springs Capital